included transient cranial nerve palsies, lower extremity weakness and paraesthesias, and bowel and bladder incontinence. Multiple previous investigations had shown only a persistent CSF pleocytosis (Table) .
In 1992, the patient had a sub-acute onset of bilateral sensorineural hearing loss, dizziness when standing, and a sensation of poor balance (worse in the dark). She began using a cane and hearing aid. The hearing loss and balance problems continued to progress slowly. In 1994, she had acute onset of horizontal diplopia and was found to have a right VI nerve palsy, which resolved completely within two weeks.
In 1995, she began to be followed by one of the authors (RG). At that time, her neurological exam was normal, as were serum ACE, HIV serology, Lyme serology, ANA, VDRL, and CXR. A CT and MRI of her brain were remarkable only for sinusitis. The sinusitis was asymptomatic and was not investigated further. (She had been seen by an ENT specialist on several occasions at the time she began to develop hearing loss). An initial lumbar puncture (LP) ( Table) showed elevated protein, decreased glucose, and lymphocytosis. This was confirmed on a repeat LP several days later. The CSF gram stain, bacterial culture, viral culture, fungal culture, cryptococcal antigen, VDRL, AFB, and p-ANCA were all negative. The CSF cytology was normal, and oligoclonal bands were absent. A third LP several months later continued to show lymphocytosis.
In 1996, she had an acute left lower motor neuron facial palsy. She received a two week course of oral prednisone, and the facial weakness resolved completely within three weeks. In 1997, she began to complain of mild leg weakness that manifested itself principally in difficulty going up stairs. There was associated decrease in sensation below her umbilicus, and occasional bowel and bladder incontinence. These new symptoms were all slowly progressive. In 1998, she had a possible nocturnal seizure and was started on both oral phenytoin and prednisone, with some improvement in her balance and no further seizures. In January 1999, as her prednisone was being tapered, she had acute worsening of her leg weakness. The prednisone was increased without improvement, and it was stopped in March 1999. Shortly afterward, she fractured her right hip after slipping in the bath. She recovered well and was stable until December when she was admitted to hospital with fever and worsened left leg weakness. She was treated with IV steroids and returned to her previous level of weakness within days.
Further investigations performed included another LP (in 1997, again showing negative cultures and AFB), a gallium scan in 1997, a myelogram in 1999, an MRI of the spine with gadolinium (T11 to S1) in January 2000, and an EMG with nerve conduction studies. All were normal.
At admission, she complained of severe leg weakness requiring a walker, decreased leg and sacral sensation, and complete lack of bowel and bladder control. Medications included phenytoin, maalox, colace, and ativan. Her past medical history included a hysterectomy, recurrent urinary tract infections, ocular laser treatment for a retinal hemorrhage due to a "blocked vein", and migraine headaches treated with naprosyn. There was no significant family history.
General physical examination was unremarkable, with no hepatosplenomegaly and no visible rash. Cranial nerves were normal apart from an inferior nasal quadrantanopsia in the right eye (secondary to the previous hemorrhage) and the bilateral hearing loss. Muscle bulk was normal, tone was slightly increased in the lower extremities, upper extremity power was normal, and lower extremity power was symmetrically decreased: iliopsoas was MRC grade 3/5, hamstrings were 4-/5, gluteus medius and quadriceps were 4/5, gastrocnemius was 4+/5, and tibialis anterior and hip adductors were 5/5. Muscle stretch reflexes were symmetrically brisk in the upper extremities, brisk in the right lower extremity, the left knee jerk was reduced, the left ankle jerk was absent, the right plantar response was flexor and the left, extensor. Coordination was normal. Vibration and joint position sensation were normal, there was clear loss of pinprick and temperature sensation on the medial right ankle and the perianal region, and decreased rectal sensation and tone. She required assistance to stand and walk.
Complete blood count, serum electrolytes, AST, ALT, alkaline phosphatase, LDH, Ca2+, ESR, ACE, and serum protein electrophoresis were normal. C-reactive protein (7.9 mg/l, normal < 5) and GGT (69 U/L, normal < 40) were slightly elevated. C-ANCA, rheumatoid factor, and anti-nuclear antibody were normal. Lumbar puncture revealed an opening pressure of 12.5, with results similar to previous (Table) . CSF cytology showed morphologically normal lymphocytes. CSF bacterial and TB cultures, India ink stain, viral PCR (for HSV, CMV, and EBV), VDRL, and ACE were all negative, and B2-microglobulin was increased (6.54 mg/L, normal approx. < 1.2 mg/L). EMG and nerve conduction studies were consistent with multiple radiculopathies in both upper and lower extremities. An MRI of the brain and spinal cord showed gadolinium enhancement of multiple cranial nerves, the basal meninges, the spinal meninges and roots, and areas of the spinal cord (Figures 1-3) . CXR, CT scan of the chest, ultrasound of the abdomen and pelvis, and gallium scan did not reveal disease outside of the nervous system. A PPD skin test was negative. A biopsy of dorsal lumbar nerve roots revealed noncaseating granulomas infiltrating the nerves (Figure 4) . A diagnosis of neurosarcoidosis was made.
Treatment was begun with oral imuran and intravenous methylprednisolone (1 gram twice per week), and the patient returned home. Three months later (June 2000), after receiving in-patient physiotherapy five days per week for the previous month, she and her husband both felt she had improved. She could walk well with a walker, and take four or five steps without it. She no longer needed laxatives and was performing intermittent bladder catheterization. She felt her sensation was improved. On neurological exam she had improved her lower extremity power by one MRC grade (e.g. 4-to 4) in each of the weak muscles. Her reflexes were unchanged. She continued on the same treatment, and three months later (September 2000) her power had again improved by one grade and she could climb stairs using hand rails. Her weekly dose of methylprednisolone was gradually decreased to 250mg per week, but she complained of burning pains in her left arm and leg that resolved when the dose was increased to 500mg. When seen recently (February 2001) she reported improved sensation on her trunk, a return of bladder sensation and slowly improving mobility. 
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DISCUSSION
Neurological symptoms are a rare manifestation of sarcoidosis, occurring in 5-15% of patients.
1-8 Isolated "neurosarcoidosis" (with only the nervous system involved) is even rarer, occurring in less than 1% of all cases 1,5 and 3-17% of those with neurological involvement. 1, 3, 5 Manifestations include meningitis, seizures, mass lesions, diabetes insipidus, cranial nerve palsies, myelopathy, neuropathy and myopathy. [3] [4] [5] [6] Isolated involvement of the cauda equina and conus medullaris has been described but is felt to be rare. [7] [8] [9] Our patient presented with signs and symptoms suggesting chronic, basal meningitis and later developed chronic, progressive leg weakness, numbness, and bowel and bladder disturbance likely caused by the granulomatous infiltration found at biopsy. The slowly progressive nature of her disease is consistent with both the reports of cauda equina involvement and isolated neurosarcoidosis in general. 5, 8 Sarcoidosis should therefore be suspected in patients presenting with chronic neurological dysfunction. Given the increasing number of case reports, it may not be as rare as once thought.
In suspected neurosarcoidosis, systemic manifestations should be looked for aggressively to confirm the diagnosis. 1, 4, 5 In our patient, CXR, chest CT, and gallium scan were all normal. 18 FDG PET scanning has also been used to detect systemic sarcoidosis. 10, 11 However, the resolution for lesions less than 10mm in size is poor 11 and therefore it is unlikely that the meningeal and nerve root infiltration seen in our patient would have been positive if 18 FDG PET scanning had been done. Others have argued that the nonspecificity of increased systemic uptake of 18 FDG, combined with the limited availability and cost of PET scanning, make its use in diagnosing sarcoidosis limited. 12 Serum ACE levels are abnormally high in up to 80% of cases of systemic sarcoidosis, 4,7 although some authors question its usefulness for diagnosis. 6 It was normal in our patient and, in fact, is rarely useful for isolated neurosarcoidosis. 7 Measurement of CSF ACE levels has been proposed as a diagnostic test, 4, 5, 7 but recently the utility of this has been questioned. 13 It was normal in our patient. Other CSF findings include elevated protein, pleocytosis, normal or decreased glucose, and elevated B2-microglobulin. All are nonspecific and highly variable in neurosarcoidosis. 4 Historically, the injection of antigen prepared from the liver or spleen of patients with sarcoidosis (the Kveim test) has been used for diagnosis but it is not well-standardized, nor commercially available. 6, 14 More recently, the Mantoux test site biopsy has been proposed as an alternative.
14 A standard forearm skin Mantoux test is done and is typically negative, but skin biopsy of the site at a later date may reveal noncaseating granulomas. Steroid therapy may interfere with this, however, and there are no case series reported that have used this technique. Neither the Kveim test nor the Mantoux test site biopsy were done in our patient.
MRI can be suggestive of the diagnosis, with high sensitivity and specificity reported by some authors. [15] [16] [17] Use of gadolinium greatly increases the sensitivity, in particular for meningeal disease. 15, 18 MRI was eventually positive in our patient, but earlier scans (including one of the spine with gadolinium enhancement) had been negative. Other authors have emphasized that the MRI appearance is nonspecific, 7, 8 especially of the spinal cord, 17 and may be negative even in cases of histologically proven sarcoidosis with clear neurological dysfunction. 16 In the most recent large series of sarcoidosis with nervous system involvement only 24 of 37 patients studies with MRI had positive findings. 3 The authors speculated that this was because of treatment, and changes in the MRI findings of CNS sarcoidosis in response to steroid treatment are well described (especially loss of gadolinium enhancement 15, 16, 19 ), however, the temporal relation between MRI and treatment for their patients was not presented. Finally, the MRI case series in sarcoidosis with nervous system involvement have included few patients with isolated CNS involvement.
Such a tremendous variety of MRI findings have been described (meningeal and cranial/spinal root enhancement, white matter lesions, parenchymal masses, hypothalamic lesions etc.) that, in the absence of systemic evidence of sarcoidosis, the diagnosis may not be considered even with an abnormal MRI. Clearly, none of the above tests are diagnostic of neurosarcoidosis. Therefore, the most important element in diagnosis is a high index of suspicion. Patients with chronic, slowly progressive neurological dysfunction in which sarcoidosis is suspected will often require biopsy for definitive diagnosis, [7] [8] [9] as ours did. Treatment and prognosis for such patients is controversial. Most authors favor prolonged treatment with corticosteroids [1] [2] [3] [4] [5] [6] but there is only anecdotal evidence to support this. Immunosuppression with azathioprine, 20 cyclosporine, 4,20,21 methotrexate, 3, 4, 20 and cyclophosphamide 3, 20 are tried as adjuvant therapy if the response to steroids is poor or side effects develop. Others use these agents only in severely ill patients. 5 Radiation treatment has also been tried. 4, 5 We elected to treat with weekly intravenous methylprednisolone and oral imuran, in the hope of maximizing treatment while avoiding the side effects of oral steroids and the stronger immunosuppressants. Prognosis with treatment is felt to be good, particularly if begun early, and up to 50% of patients may remit. 1, [4] [5] [6] With longer duration of symptoms, such as in our patient, the chance of complete recovery is much less 8 but significant improvement can be obtained. Physiotherapy can also play an important role in helping patients regain some degree of functional independence, 9 and our patient certainly seemed to benefit. Both treatment and prognosis clearly need to be individualized.
In summary, our case is exceptional in the duration and variety of neurological complaints. It points out the need for both a high index of suspicion for the diagnosis of neurosarcoidosis and for aggressive investigations to pursue this. In patients with suspected involvement of the cauda equina careful MRI examination with, and without, gadolinium should be performed, and there should be a low threshold for consideration of biopsy.
